KEMTUB012-NI2, a novel potent tubulysin analog that selectively targets hypoxic cancer cells and is potentiated by cytochrome p450 reductase downregulation
| dc.contributor.author | Lazzari, Paolo | |
| dc.contributor.author | Spiga, Marco | |
| dc.contributor.author | Sani, Monica | |
| dc.contributor.author | Zanda, Matteo | |
| dc.contributor.author | Fleming, Ian N | |
| dc.contributor.institution | University of Aberdeen.Medical Sciences | en |
| dc.contributor.institution | University of Aberdeen.Medical Sciences - Cardiovascular Group | en |
| dc.contributor.institution | University of Aberdeen.Medical Education | en |
| dc.contributor.institution | University of Aberdeen.Aberdeen Biomedical Imaging Centre | en |
| dc.date.accessioned | 2017-05-25T10:00:09Z | |
| dc.date.available | 2017-05-25T10:00:09Z | |
| dc.date.issued | 2017-05-23 | |
| dc.description.status | Peer reviewed | en |
| dc.format.extent | 15 | |
| dc.format.extent | 1630699 | |
| dc.identifier | 101152609 | |
| dc.identifier | 1d16d9c6-78e0-4a45-a5f8-7f2f806561f7 | |
| dc.identifier.citation | Lazzari, P, Spiga, M, Sani, M, Zanda, M & Fleming, I N 2017, 'KEMTUB012-NI2, a novel potent tubulysin analog that selectively targets hypoxic cancer cells and is potentiated by cytochrome p450 reductase downregulation', Hypoxia, vol. 5, pp. 45-59. https://doi.org/10.2147/HP.S132832 | en |
| dc.identifier.doi | 10.2147/HP.S132832 | |
| dc.identifier.other | ORCID: /0000-0001-9505-6418/work/86450269 | |
| dc.identifier.uri | http://hdl.handle.net/2164/8690 | |
| dc.identifier.vol | 5 | en |
| dc.language.iso | eng | |
| dc.relation.ispartof | Hypoxia | en |
| dc.subject | SDG 3 - Good Health and Well-being | en |
| dc.subject | breast cancer | en |
| dc.subject | tubulysin | en |
| dc.subject | anti-mitotic | en |
| dc.subject | hypoxia | en |
| dc.subject | cell death | en |
| dc.subject | reductase | en |
| dc.subject | R Medicine | en |
| dc.subject.lcc | R | en |
| dc.title | KEMTUB012-NI2, a novel potent tubulysin analog that selectively targets hypoxic cancer cells and is potentiated by cytochrome p450 reductase downregulation | en |
| dc.type | Journal article | en |
